about
Pharmaceutical policies: effects on rational drug useBarriers to self-monitoring of blood glucose among adults with diabetes in an HMO: a cross sectional studyUnderstanding the Role of Accredited Drug Dispensing Outlets in Tanzania's Health SystemEffect of switching to a high-deductible health plan on use of chronic medicationsImpact of universal health insurance coverage in Thailand on sales and market share of medicines for non-communicable diseases: an interrupted time series study.Improving diabetes care among patients overdue for recommended testing: a randomized controlled trial of automated telephone outreach.A retrospective data analysis of the impact of the New York triplicate prescription program on benzodiazepine use in medicaid patients with chronic psychiatric and neurologic disorders.Impact of a 16-community trial to promote judicious antibiotic use in Massachusetts.Interventions designed to improve the quality and efficiency of medication use in managed care: a critical review of the literature - 2001-2007Costs of hospital care for hypertension in an insured population without an outpatient medicines benefit: an observational study in the Philippines.A descriptive review of the methodologies used in household surveys on medicine utilization.Racial differences in long-term adherence to oral antidiabetic drug therapy: a longitudinal cohort study.Mobile Phone and Smartphone Technologies for Diabetes Care and Self-Management.Measuring adherence to antiretroviral treatment in resource-poor settings: the clinical validity of key indicators.Measuring adherence to antiretroviral treatment in resource-poor settings: the feasibility of collecting routine data for key indicators.Comparing simulation and threshold approaches when analysing data with probabilities of categories.Availability and use of essential medicines in China: manufacturing, supply, and prescribing in Shandong and Gansu provinces.Effects of Medicare Part D on guideline-concordant pharmacotherapy for bipolar I disorder among dual beneficiaries.Improving adherence to antiretroviral treatment in Uganda with a low-resource facility-based intervention.Health insurance systems in five Sub-Saharan African countries: medicine benefits and data for decision making.Some families who purchased health coverage through the Massachusetts Connector wound up with high financial burdens.A new measure of medication affordabilityImpact of pharmaceutical policy interventions on utilization of antipsychotic medicines in Finland and Portugal in times of economic recession: interrupted time series analyses.Changes in use of lipid-lowering medications among black and white dual enrollees with diabetes transitioning from Medicaid to Medicare Part D drug coverage.Rapid increase in breast magnetic resonance imaging use: trends from 2000 to 2011.Quality use of medicines within universal health coverage: challenges and opportunitiesLack of relationship between long-term use of benzodiazepines and escalation to high dosages.Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: matched pair analysis.Evaluating quality of care for patients with type 2 diabetes using electronic health record information in Mexico.Development of a Mapped Diabetes Community Program Guide for a Safety Net Population.Access to medicines for acute illness in middle income countries in Central AmericaEffect of the economic recession on pharmaceutical policy and medicine sales in eight European countries.Effect of pay for performance on the management and outcomes of hypertension in the United Kingdom: interrupted time series study.Essential medicines for universal health coverage.The association of television and video viewing with fast food intake by preschool-age children.Need for and access to health care and medicines: are there gender inequities?Association between prior authorization for medications and health service use by Medicaid patients with bipolar disorderBeliefs and expectations of women under 50 years old regarding screening mammography: a qualitative study.Facility-level intervention to improve attendance and adherence among patients on anti-retroviral treatment in Kenya--a quasi-experimental study using time series analysis.Out-of-pocket burden of health care spending and the adequacy of the Medicare Part D low-income subsidy.
P50
Q24244044-6E823D76-A978-4388-80D5-C64990A9844FQ24793064-45FFEC0F-A1D3-423D-A8A8-CB4C68479874Q28553263-E6994CED-72BA-4534-8132-B37FAE132F5FQ28743191-9C542FEB-1B35-4C68-9E4A-AAFF83814924Q30394441-277C649D-0AA6-406F-A612-BB8DC25123E2Q30495041-55936025-3F30-4507-84E5-EB17E9A8F834Q30915154-F6880840-153A-4543-B4FD-DBADCA2A95BDQ33312892-94F94BA9-8F4B-418A-B23C-627353B9F7C0Q33327179-955E6EFC-6E03-4E1C-B02F-32F7DAB5759BQ33355842-9CC65E53-9B0A-45CA-A8F6-C2233B865F72Q33381843-29BBE819-2C85-42EE-AACE-C8343AA6800FQ33406650-12781E65-9968-4B56-AE14-1E2F1161288DQ33445438-3D2D711B-0583-4FF0-A43F-2E32B3F4FAF1Q33532758-BCFE2B3E-E756-47F0-AD30-9F71931E0356Q33532759-C235A2A0-4E56-4B82-B0BF-2EFA1B85C8E7Q33619708-C2E1AA96-99C9-41E0-833D-7F1F5C2CAC4EQ33634671-A428482B-89E9-4725-8714-2DCFC927AA0CQ33687751-6D67C969-D20D-4A0D-B0C1-4AC70A65F62EQ33725057-9194249D-5050-4289-B7A0-B681495C7E9AQ33774871-12F860C6-150D-4161-B6BC-A794A34732CAQ33920620-38E2B4FF-590C-4826-AD38-34EF72C213B5Q33945830-7B68EF1F-21AE-4F91-947A-0D60C3491DFBQ34020812-E765D74C-6A53-41D4-8BC7-19D5183F509CQ34055633-C86084E1-1AC0-4519-BE2B-66CA9220B092Q34094242-B79C8EC8-5B24-4DE7-B5F5-43A479AB18A8Q34151454-185D14DA-3A99-4A91-A51E-68090143F2A7Q34212855-FAE5C459-9B3C-4F35-B775-8DEAE51EC7A9Q34276216-43FF4949-02FE-4560-9C2B-10DB3E9EE73EQ34294366-8B59637D-653B-46EF-BBBD-FDB95A9C10DBQ34381541-9D572924-E877-4663-8E08-BCDEC649B71FQ34386222-18B72735-BDCD-487F-8788-D7647990AED1Q34399553-8F1AAEE0-1D57-4BE4-A7D4-85DF4C92B5B5Q34520451-BB28AB66-BE42-42BC-A99B-6AFEB8872611Q34544415-4C119DED-1077-4F1C-99C5-C602B08B5014Q34585900-B28C52B0-2649-4B06-9F1C-612F59A451C2Q34625496-19ECF1CD-2EA6-4542-AB9D-F9E53C1F7A5DQ34645789-CCB70B42-BF06-4D07-B0BE-29EEC55ABCFCQ34741240-3F09E52B-5A43-4185-B29E-CF82B2E67D14Q34788589-4EAB65CA-3165-4B89-BE17-297AB2E5CC57Q34886245-631460B1-A8B4-4DD9-B242-DA8D675A8857
P50
name
Dennis Ross-Degnan
@en
type
label
Dennis Ross-Degnan
@en
prefLabel
Dennis Ross-Degnan
@en